Chapter 63: The Lab Assistant
Theo Bell began by admitting he had stayed silent.
"Five years ago, I needed the job," he said. "When Sterling said Dr. Evelyn Sterling had controlled the disputed work, I did not correct anyone outside my team."
He was thirty now. In the research years, he had been a junior assistant assigned to my group.
The tribunal reminded him that fear did not make his current testimony true. Records would test every statement.
Theo agreed.
He identified my hypothesis memo, the meeting where I first divided the platform problem into its core conceptual parts, and the draft diagram he formatted from my handwritten instructions. His initials appeared in the file history as the person who converted my notes into presentation form.
The tribunal showed him three masked claim descriptions and asked whether he remembered their origin separately. He identified two from meetings he attended and refused to answer the third.
"I remember formatting it," he said. "I do not remember the discussion well enough to name everyone present."
That refusal mattered. He was not filling every gap in my favor.
The tribunal trusted the boundary because he kept it when it cost me.
Limits made him credible.
"Did you contribute the core hypothesis?" Sterling's counsel asked.
"No."
"Then why did the investor slide call you a concept lead?"
"The brand team wanted a young scientist visible during the demonstration."
"Did Dr. Sterling object?"
"I do not know whether she saw that title."
He refused to help me beyond his knowledge.
The chair turned to Celeste.
"What did you observe her contribute?"
Theo described Celeste's visits before investor tours. She checked which explanations sounded clear, asked how long a demonstration would take, and adjusted the sequence of the room visit.
"Did she attend the hypothesis sessions?"
"Not the ones I attended."
"Did she edit the original research memo?"
"Not in the version history I maintained."
Celeste's counsel produced calendars showing her inside the laboratory building on several research dates.
Theo studied them.
"Those were investor visits."
"You remember every visit after five years?"
"No. I remember the visitor packets because I prepared them."
The packets matched the calendar entries.
Theo also admitted that Celeste sometimes discussed broad goals with me in hallways. She wanted a platform that could be explained quickly and funded at scale. None of those conversations produced the claim elements the tribunal was mapping.
Sterling counsel asked whether her pressure ever changed my priorities.
"It changed deadlines," Theo said. "I cannot identify a scientific concept she supplied."
"Could she have discussed one when you were absent?"
"Yes."
"Then you cannot exclude her."
"I can only tell you what I saw."
The tribunal recorded the limitation beside his testimony.
"Are you loyal to Evelyn now?" Celeste asked when allowed one direct question.
"I am represented separately and employed elsewhere."
"That was not my question."
"I was not loyal enough to speak five years ago."
His answer cost him the cleaner role of brave witness. It made the rest harder to dismiss as devotion.
Theo authenticated a research author list from before the accident. My name appeared first. His appeared as technical support. Celeste did not appear in the scientific author field.
That list did not decide the patent. It showed how the working team described contribution before a crisis changed the incentives.
The tribunal admitted Theo's testimony with limits: direct observation of my hypothesis work, his own formatting role, and Celeste's investor-related visits. It refused to treat his silence as proof of any fact he had not witnessed.
When he left, he did not ask me for forgiveness.
The records auditor opened the version history attached to the author list.
My name had not stayed first.
After the incident, it moved down.
Then it disappeared.